Key result
Combined morning and nocturnal hypertension was associated with a higher risk of left ventricular hypertrophy (OR 2.87; 95% CI 2.01-4.09) and low eGFR (OR 3.18; 95% CI 2.23-4.54) in CKD patients.
Why the study?
Although morning hypertension and nocturnal hypertension are linked to target organ damage in CKD, their isolated or combined effects remained less well-defined.
Does morning and/or nocturnal hypertension increase the risk of target organ damage in non-dialysis CKD patients?
Cross-Sectional (n=2,386)
Does morning and/or nocturnal hypertension increase the risk of target organ damage in non-dialysis CKD patients?
Combined morning and nocturnal hypertension is associated with significantly increased risks of cardiovascular and renal target organ damage in non-dialysis CKD patients.
Both morning hypertension (MH) and nocturnal hypertension (NH) are associated with severe target organ damage in patients with chronic kidney disease (CKD). However, the isolated or combined effects of MH and NH on target organ damage are less well-defined. A cross-sectional study was conducted among 2386 non-dialysis CKD patients with ambulatory blood pressure monitoring. The authors categorized patients into four groups based on the presence or absence of MH and NH. Multivariate logistic analyses were used to evaluate the correlation between hypertension subtypes and target organ damage, including left ventricular hypertrophy (LVH), abnormal carotid intima-media thickness (CIMT), low estimated glomerular filtration rate (eGFR), and albuminuria. The percentages of isolated MH, isolated NH, and combined MH and NH were 2.3%, 24.0%, and 49.3%, respectively. Compared to patients without MH and NH, isolated MH was only related to low eGFR (2.26 [95% confidence interval: 1.00-5.09]) and albuminuria (2.17 [95% CI: 1.03-4.54]). Meanwhile, combined MH and NH group compared to the group without MH and NH had a higher risk of LVH (2.87 [95% CI: 2.01-4.09]), abnormal CIMT (2.01 [95% CI: 1.47-2.75]), low eGFR (3.18 [95% CI: 2.23-4.54]), and albuminuria (1.79 [95% CI: 1.33-2.40]), even in patients without daytime hypertension. The risk of cardiovascular and renal damage was also observed in the isolated NH group. In conclusion, morning hypertension is associated with kidney dysfunction and has combined effects with nocturnal hypertension on cardiovascular damage in chronic kidney disease patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) conducted a cross-sectional in chronic kidney disease (n=2,386). Combined morning and nocturnal hypertension vs. No morning and nocturnal hypertension was evaluated on Left ventricular hypertrophy (OR 2.87, 95% CI 2.01-4.09). Combined morning and nocturnal hypertension was associated with a higher risk of left ventricular hypertrophy (OR 2.87; 95% CI 2.01-4.09) and low eGFR (OR 3.18; 95% CI 2.23-4.54) in CKD patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: